| Primary |
| Postoperative Care |
11.4% |
| Lymphoma |
10.0% |
| Product Used For Unknown Indication |
10.0% |
| Gastritis |
8.6% |
| Nasopharyngitis |
7.9% |
| Hypertension |
5.7% |
| Prophylaxis |
5.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.0% |
| Acoustic Neuroma |
4.3% |
| Hypertonic Bladder |
4.3% |
| Rheumatoid Arthritis |
4.3% |
| Epilepsy |
3.6% |
| Abdominal Discomfort |
2.9% |
| Congestive Cardiomyopathy |
2.9% |
| Suicide Attempt |
2.9% |
| Abdominal Pain Upper |
2.1% |
| Antibiotic Therapy |
2.1% |
| Diabetes Mellitus |
2.1% |
| Endocarditis |
2.1% |
| Fibromyalgia |
2.1% |
|
| Intentional Drug Misuse |
10.0% |
| Off Label Use |
8.0% |
| Rhabdomyolysis |
8.0% |
| Pyrexia |
6.0% |
| Stevens-johnson Syndrome |
6.0% |
| Tubulointerstitial Nephritis |
6.0% |
| Ageusia |
4.0% |
| Dementia |
4.0% |
| Drug-induced Liver Injury |
4.0% |
| Electrocardiogram Qt Prolonged |
4.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Hypokalaemia |
4.0% |
| Liver Disorder |
4.0% |
| Liver Function Test Abnormal |
4.0% |
| Loss Of Consciousness |
4.0% |
| Nausea |
4.0% |
| Platelet Count Decreased |
4.0% |
| Rash Papular |
4.0% |
| Renal Impairment |
4.0% |
| Thrombosis |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
23.5% |
| Ill-defined Disorder |
18.8% |
| Drug Use For Unknown Indication |
9.7% |
| Hypertension |
9.4% |
| Gastritis |
4.1% |
| Prophylaxis |
3.1% |
| Glomerulonephritis Membranous |
3.0% |
| Premedication |
2.9% |
| Rheumatoid Arthritis |
2.8% |
| Constipation |
2.7% |
| Pneumonia |
2.7% |
| Pyrexia |
2.4% |
| Diabetes Mellitus |
2.1% |
| Epilepsy |
2.1% |
| Thrombotic Cerebral Infarction |
2.1% |
| Insomnia |
1.9% |
| Gastric Ulcer |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Myocardial Infarction |
1.7% |
| Hyperlipidaemia |
1.6% |
|
| Hepatic Function Abnormal |
12.7% |
| Toxic Epidermal Necrolysis |
10.7% |
| Platelet Count Decreased |
8.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
8.0% |
| Pyrexia |
8.0% |
| Liver Disorder |
7.3% |
| White Blood Cell Count Decreased |
7.3% |
| Thrombocytopenia |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Rhabdomyolysis |
3.3% |
| Diabetes Insipidus |
2.7% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.7% |
| Interstitial Lung Disease |
2.7% |
| Peripheral Embolism |
2.7% |
| Pulmonary Artery Thrombosis |
2.7% |
| Renal Failure |
2.7% |
| Staphylococcal Infection |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
| Vomiting |
2.7% |
| Agranulocytosis |
2.0% |
|
| Concomitant |
| Prophylaxis |
19.9% |
| Rheumatoid Arthritis |
13.6% |
| Drug Use For Unknown Indication |
11.4% |
| Hypertension |
10.3% |
| Gastritis |
5.0% |
| Product Used For Unknown Indication |
4.6% |
| Diabetes Mellitus |
3.9% |
| Constipation |
3.2% |
| Insomnia |
3.1% |
| Gastric Ulcer |
2.9% |
| Infection Prophylaxis |
2.7% |
| Pneumonia |
2.7% |
| Chronic Hepatitis C |
2.6% |
| Osteoporosis |
2.3% |
| Cancer Pain |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
| Hepatitis C |
2.1% |
| Premedication |
1.8% |
| Asthma |
1.8% |
| Multiple Myeloma |
1.7% |
|
| White Blood Cell Count Decreased |
14.8% |
| Pyrexia |
9.8% |
| Pneumonia |
6.6% |
| Interstitial Lung Disease |
6.5% |
| Vomiting |
6.1% |
| Renal Impairment |
5.7% |
| Hepatic Function Abnormal |
5.5% |
| Rash |
5.2% |
| Platelet Count Decreased |
5.0% |
| Liver Disorder |
4.9% |
| Sepsis |
4.1% |
| Renal Failure Acute |
3.7% |
| Rhabdomyolysis |
3.7% |
| White Blood Cell Count Increased |
3.6% |
| Somnolence |
2.8% |
| Death |
2.6% |
| Pneumocystis Jiroveci Pneumonia |
2.6% |
| Respiratory Failure |
2.5% |
| Thrombocytopenia |
2.1% |
| Stomatitis |
2.0% |
|
| Interacting |
| Hypertension |
33.3% |
| Arteritis Obliterans |
11.1% |
| Cerebral Infarction |
11.1% |
| Diabetes Mellitus |
11.1% |
| Lipid Metabolism Disorder |
11.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.1% |
| Wound Infection |
11.1% |
|
| Ventricular Tachycardia |
100.0% |
|
